rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-12-18
|
pubmed:abstractText |
We examined short-term outcomes and posttransplant medical complications under three different immunosuppressive regimens at a single center. The study design was a randomized, prospective, open-label trial comparing a calcineurin inhibitor-free (CNI) protocol to standard triple therapy with tacrolimus, prednisone, and mycophenolate mofetil. They were also compared to a concurrent but nonrandomized third cohort treated with a prednisone-free protocol. All three groups had excellent early outcomes with no significant difference in patient or graft survival or biopsy-proven acute rejection. Serum creatinine was significantly lower in the CNI-free recipients. Lipid panels and posttransplant diabetes mellitus were significantly lower in the prednisone-free patients. Prednisone-free kidney transplant recipients have improved early glucose metabolism and hyperlipidemia compared to CNI-free or standard triple therapy recipients with comparable rejection and graft survival rates.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0041-1345
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3466-7
|
pubmed:meshHeading |
pubmed-meshheading:17175305-Adrenal Cortex Hormones,
pubmed-meshheading:17175305-Biopsy,
pubmed-meshheading:17175305-Creatinine,
pubmed-meshheading:17175305-Drug Therapy, Combination,
pubmed-meshheading:17175305-Graft Rejection,
pubmed-meshheading:17175305-Graft Survival,
pubmed-meshheading:17175305-Histocompatibility Testing,
pubmed-meshheading:17175305-Humans,
pubmed-meshheading:17175305-Immunosuppressive Agents,
pubmed-meshheading:17175305-Kidney Transplantation,
pubmed-meshheading:17175305-Living Donors,
pubmed-meshheading:17175305-Methylprednisolone,
pubmed-meshheading:17175305-Mycophenolic Acid,
pubmed-meshheading:17175305-Prednisone,
pubmed-meshheading:17175305-Sirolimus,
pubmed-meshheading:17175305-Survival Analysis,
pubmed-meshheading:17175305-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Short-term results under three different immunosuppressive regimens at one center.
|
pubmed:affiliation |
Division of Kidney and Pancreas Transplantation, Vanderbilt University Medical Center, Nashville, Tennessee 37232-4750, USA.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|